{"id":"https://openalex.org/W4296325200","doi":"https://doi.org/10.1158/1535-7163.mct-21-0962","title":"Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein \u03b2","display_name":"Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein \u03b2","publication_year":2022,"publication_date":"2022-09-16","ids":{"openalex":"https://openalex.org/W4296325200","doi":"https://doi.org/10.1158/1535-7163.mct-21-0962","pmid":"https://pubmed.ncbi.nlm.nih.gov/36121385","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9630826"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-21-0962","doi":"https://doi.org/10.1158/1535-7163.mct-21-0962","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0962","pdf_url":"https://aacrjournals.org/mct/article-pdf/21/11/1632/3218932/1632.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aacrjournals.org/mct/article-pdf/21/11/1632/3218932/1632.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004632995","display_name":"Emad Darvishi","orcid":"https://orcid.org/0000-0003-4209-6162","observed_orcids":["https://orcid.org/0000-0003-4209-6162"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emad Darvishi","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0003-4209-6162","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050001576","display_name":"Lila Ghamsari","orcid":"https://orcid.org/0000-0002-8914-2114","observed_orcids":["https://orcid.org/0000-0002-8914-2114"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lila Ghamsari","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0002-8914-2114","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059555757","display_name":"Siok F. Leong","orcid":"https://orcid.org/0000-0003-0011-3999","observed_orcids":["https://orcid.org/0000-0003-0011-3999"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siok F. Leong","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0003-0011-3999","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029317866","display_name":"Ricardo Ramirez","orcid":"https://orcid.org/0000-0003-3453-6164","observed_orcids":["https://orcid.org/0000-0003-3453-6164"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Ramirez","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0003-3453-6164","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044206005","display_name":"Mark Koester","orcid":"https://orcid.org/0000-0003-4559-6568","observed_orcids":["https://orcid.org/0000-0003-4559-6568"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Koester","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0003-4559-6568","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015853909","display_name":"Erin Gallagher","orcid":"https://orcid.org/0000-0002-6020-9418","observed_orcids":["https://orcid.org/0000-0002-6020-9418"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Gallagher","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0002-6020-9418","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051116047","display_name":"Miao Yu","orcid":"https://orcid.org/0000-0003-1743-4043","observed_orcids":["https://orcid.org/0000-0003-1743-4043"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miao Yu","raw_affiliation_strings":["2Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-1743-4043","affiliations":[{"raw_affiliation_string":"2Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004541105","display_name":"Jody M. Mason","orcid":"https://orcid.org/0000-0002-4118-1958","observed_orcids":["https://orcid.org/0000-0002-4118-1958"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jody M. Mason","raw_affiliation_strings":["2Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-4118-1958","affiliations":[{"raw_affiliation_string":"2Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040301527","display_name":"Gene Merutka","orcid":"https://orcid.org/0000-0001-5447-2554","observed_orcids":["https://orcid.org/0000-0001-5447-2554"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gene Merutka","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0001-5447-2554","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089113472","display_name":"Barry J. Kappel","orcid":"https://orcid.org/0000-0002-0344-8826","observed_orcids":["https://orcid.org/0000-0002-0344-8826"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry J. Kappel","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0002-0344-8826","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048924826","display_name":"Jimmy A. Rotolo","orcid":"https://orcid.org/0000-0003-4195-6167","observed_orcids":["https://orcid.org/0000-0003-4195-6167"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jim A. Rotolo","raw_affiliation_strings":["1Sapience Therapeutics, Inc., Harrison, New York"],"raw_orcid":"https://orcid.org/0000-0003-4195-6167","affiliations":[{"raw_affiliation_string":"1Sapience Therapeutics, Inc., Harrison, New York","institution_ids":["https://openalex.org/I4405263104"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5048924826"],"corresponding_institution_ids":["https://openalex.org/I4405263104"],"apc_list":null,"apc_paid":null,"fwci":1.5499,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.84148792,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"21","issue":"11","first_page":"1632","last_page":"1644"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.2506999969482422,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.2506999969482422,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.14069999754428864,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.12939999997615814,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/st101","display_name":"ST101","score":1.0},{"id":"https://openalex.org/keywords/c-ebpbeta","display_name":"C/EBP\u03b2","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cebpb","display_name":"CEBPB","score":0.8820000290870667},{"id":"https://openalex.org/keywords/peptide-antagonists","display_name":"peptide antagonists","score":0.7919999957084656},{"id":"https://openalex.org/keywords/leucine-zipper-domain","display_name":"leucine zipper domain","score":0.8360000252723694},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-degradation","display_name":"ubiquitin-proteasome degradation","score":0.9879999756813049},{"id":"https://openalex.org/keywords/transcriptional-repression","display_name":"transcriptional repression","score":0.7160000205039978},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8790000081062317},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7080000042915344},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C156860981","wikidata":"https://www.wikidata.org/wiki/Q2565229","display_name":"Leucine zipper","level":4,"score":0.6097778677940369},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.5712448358535767},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5568187236785889},{"id":"https://openalex.org/C149240914","wikidata":"https://www.wikidata.org/wiki/Q907967","display_name":"Ccaat-enhancer-binding proteins","level":5,"score":0.5484737157821655},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5122377276420593},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4358724355697632},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40246713161468506},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40154504776000977},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2539892792701721},{"id":"https://openalex.org/C29512474","wikidata":"https://www.wikidata.org/wiki/Q16860021","display_name":"Nuclear protein","level":4,"score":0.19353511929512024},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17995870113372803}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D022782","descriptor_name":"CCAAT-Enhancer-Binding Protein-beta","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-21-0962","doi":"https://doi.org/10.1158/1535-7163.mct-21-0962","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0962","pdf_url":"https://aacrjournals.org/mct/article-pdf/21/11/1632/3218932/1632.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:36121385","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36121385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9630826","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9630826/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-21-0962","doi":"https://doi.org/10.1158/1535-7163.mct-21-0962","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0962","pdf_url":"https://aacrjournals.org/mct/article-pdf/21/11/1632/3218932/1632.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G376480784","display_name":"Efficacy and PK/PD of a C/EBP beta antagonist in orthotopic breast cancer","funder_award_id":"R43CA250786","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7622000911","display_name":null,"funder_award_id":"R43CA250786","funder_id":"https://openalex.org/F4320338417","funder_display_name":"Basic Research Laboratory"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320338417","display_name":"Basic Research Laboratory","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4296325200.pdf","grobid_xml":"https://content.openalex.org/works/W4296325200.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W321874077","https://openalex.org/W1835542029","https://openalex.org/W1859099271","https://openalex.org/W1966222920","https://openalex.org/W1977380334","https://openalex.org/W1977898585","https://openalex.org/W1983683479","https://openalex.org/W1988903498","https://openalex.org/W1990518755","https://openalex.org/W1998093640","https://openalex.org/W1998989200","https://openalex.org/W2008570049","https://openalex.org/W2011789447","https://openalex.org/W2015970511","https://openalex.org/W2022139382","https://openalex.org/W2037455416","https://openalex.org/W2048634508","https://openalex.org/W2048789360","https://openalex.org/W2052622098","https://openalex.org/W2052671828","https://openalex.org/W2053983828","https://openalex.org/W2068077937","https://openalex.org/W2069634494","https://openalex.org/W2076194625","https://openalex.org/W2077393774","https://openalex.org/W2078933151","https://openalex.org/W2085069795","https://openalex.org/W2091285832","https://openalex.org/W2102632906","https://openalex.org/W2107277218","https://openalex.org/W2114360920","https://openalex.org/W2118814319","https://openalex.org/W2121091904","https://openalex.org/W2122731747","https://openalex.org/W2129011493","https://openalex.org/W2142800313","https://openalex.org/W2154500525","https://openalex.org/W2160450758","https://openalex.org/W2171846923","https://openalex.org/W2343933131","https://openalex.org/W2580806228","https://openalex.org/W2896718367","https://openalex.org/W2913533941","https://openalex.org/W2973216672","https://openalex.org/W3027679488","https://openalex.org/W3090689859","https://openalex.org/W3130747086"],"related_works":["https://openalex.org/W4220840833","https://openalex.org/W3082993800","https://openalex.org/W3180962256","https://openalex.org/W4308448224","https://openalex.org/W4283361280","https://openalex.org/W3164386193","https://openalex.org/W4282966621","https://openalex.org/W4389227755","https://openalex.org/W3179718790","https://openalex.org/W4409636023"],"abstract_inverted_index":{"CCAAT/enhancer":[0],"binding":[1,34],"protein":[2],"\u03b2":[3],"(C/EBP\u03b2)":[4],"is":[5,15,83,137],"a":[6,24,52,74,120,183,206],"basic":[7],"leucine":[8,97],"zipper":[9,98],"(bZIP)":[10],"family":[11],"transcription":[12,114,127],"factor,":[13],"which":[14],"upregulated":[16],"or":[17,179],"overactivated":[18],"in":[19,23,85,88,123,140,144,167,174,187],"many":[20],"cancers,":[21],"resulting":[22],"gene":[25],"expression":[26,124],"profile":[27],"that":[28,47,82],"drives":[29],"oncogenesis.":[30],"C/EBP\u03b2":[31,81,109,116],"dimerization":[32,50,104],"regulates":[33],"to":[35,55],"DNA":[36],"at":[37],"the":[38,65,96,193],"canonical":[39],"TTGCGCAA":[40],"motif":[41],"and":[42,69,76,105,129,153,160,186,198],"subsequent":[43],"transcriptional":[44],"activity,":[45],"suggesting":[46],"disruption":[48],"of":[49,67,72,80,100,115,125,134,196,203],"represents":[51],"powerful":[53],"approach":[54],"inhibit":[56],"this":[57],"previously":[58],"\"undruggable\"":[59],"oncogenic":[60],"target.":[61],"Here":[62],"we":[63],"describe":[64],"mechanism":[66],"action":[68],"antitumor":[70],"activity":[71,143],"ST101,":[73,197],"novel":[75,207],"selective":[77],"peptide":[78],"antagonist":[79],"currently":[84],"clinical":[86,201],"evaluation":[87],"patients":[89],"with":[90],"advanced":[91],"solid":[92],"tumors.":[93],"ST101":[94,111,135,171,204],"binds":[95],"domain":[99],"C/EBP\u03b2,":[101],"preventing":[102],"its":[103],"enhancing":[106],"ubiquitin-proteasome":[107],"dependent":[108],"degradation.":[110],"exposure":[112,136,172],"attenuates":[113],"target":[117],"genes,":[118],"including":[119,148],"significant":[121],"decrease":[122],"survival,":[126],"factors,":[128],"cell-cycle-related":[130],"proteins.":[131],"The":[132],"result":[133],"potent,":[138],"tumor-specific":[139],"vitro":[141],"cytotoxic":[142],"cancer":[145],"cell":[146],"lines":[147],"glioblastoma,":[149],"breast,":[150],"melanoma,":[151],"prostate,":[152],"lung":[154],"cancer,":[155],"whereas":[156],"normal":[157],"human":[158],"immune":[159],"epithelial":[161],"cells":[162],"are":[163],"not":[164],"impacted.":[165],"Further,":[166],"mouse":[168],"xenograft":[169],"models":[170],"results":[173],"potent":[175],"tumor":[176],"growth":[177],"inhibition":[178],"regression,":[180],"both":[181],"as":[182,205],"single":[184],"agent":[185],"combination":[188],"studies.":[189],"These":[190],"data":[191],"provide":[192],"First":[194],"Disclosure":[195],"support":[199],"continued":[200],"development":[202],"strategy":[208],"for":[209],"targeting":[210],"C/EBP\u03b2-dependent":[211],"cancers.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-09-20T00:00:00"}